about
Mitochondrial Redox Signaling and Tumor ProgressionAnti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitorLipoplexes and tumours. A review.The role of angiogenesis in rheumatoid arthritis: recent developmentsTumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon SystemRestoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.Therapeutic vaccination with tumor cells that engage CD137.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?The therapeutic potential of novel antiangiogenic therapies.CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.Molecular biological design of novel antineoplastic therapies.DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis.Endostatin gene therapy for liver cancer by a recombinant adenovirus deliveryRetrovirus-mediated gene transfer of human endostatin inhibits growth of human liver carcinoma cells SMMC7721 in nude mice.Cloning and identification of an angiostatic molecule IP10/crg -2Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice.Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor.Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis.Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapyFusion of the tissue factor extracellular domain to a tumour stroma specific single-chain fragment variable antibody results in an antigen-specific coagulation-promoting molecule.NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells.Anti-tumor effect of lentivirus-mediated gene transfer of alphastatin on human glioma.Metastatic properties of prostate cancer cells are controlled by VEGF.Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor.Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro.Expression of antisense to integrin subunit beta 3 inhibits microvascular endothelial cell capillary tube formation in fibrin.A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors.Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery.Intraperitoneal gene therapy by rAAV provides long-term survival against epithelial ovarian cancer independently of survivin pathway.Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis.Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model.Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes.Effects of lentivirus-mediated endostatin on endothelial progenitor cells.Tissue-specific gene therapy directed to tumor angiogenesis.Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma.
P2860
Q26749592-53C8D174-9948-47D5-A4EB-9B17930BFA62Q28297894-CCA949F7-BCF3-44EF-B238-5A600D1E2B95Q33723073-D0598BAC-FA07-4B78-90DE-94FDAAE2BC7AQ34071300-641F0E2C-F629-4E47-8F05-C9347130C504Q34221867-5F13E20C-CDE3-4E4B-ABC7-D045CA1BA689Q34608072-8FB60F9A-8CD9-42B6-89F5-8467ABED2BA6Q34683461-299B1738-F02B-498E-96C7-C2FBFC8F5169Q34786160-6C139054-212B-4D4A-A67D-06C27E332F4BQ35071688-A51F9695-5CA0-4737-AFC6-A16BC939684AQ35142329-33512FC3-2BFD-45DB-8D17-EE91A5A1C659Q35143984-D5E98FFF-77B1-407C-BF38-4795CEF97BAAQ35558644-8685E25C-6AB1-46FE-BC5B-FE5568F930B4Q35790781-B5D7FF19-F9CD-44BD-9126-6F0D7ADB0449Q35826396-E84864E5-0211-4FA2-856C-231968FFBD9DQ36065853-B18F6C71-D9C3-4861-9AA4-5DD32B9CF1EBQ36308382-DCC8043C-65D4-4CA8-94DF-EA0F0565031CQ36396776-CA67152C-E0DA-4ECB-8E2F-DDEFE7EEB8EAQ36468368-89AE851B-479A-4DF8-B3A5-09B4E0B9AA80Q36484817-D309795A-9C72-4CBC-A3B5-1D12AD7B882CQ37118147-220FADC8-157F-4407-A29C-03F9A3420187Q37322679-3800C68F-6176-43A5-82A4-06683C82ACA2Q38310432-41BC4F1B-E88C-412D-955E-639B9A58DEDFQ39301482-7FE17036-047E-479B-8990-BFDF940E3A28Q39585178-E084B001-D7B4-460A-9FA7-90BF1F0DBBF3Q39604681-EDDCC763-9F07-485E-B089-FD038094F2E7Q40500872-9EE4EE57-2D67-4455-BAED-39991C9B8597Q40516867-C7C19C01-0347-4DB4-921A-C1F3DF4533B5Q40741131-A71BA9EE-4EE7-42D6-8E63-CAC9645BE9AFQ40865226-6C5E91BE-5CCA-4955-9AC9-069655DB9F8FQ42759889-C141BA68-55A5-4839-8873-CB30A8892182Q45108563-93E8FC68-27DF-4BCA-A78A-8E94A7D83807Q45858411-10D49817-C1A8-41E8-AA3C-4EC44B594172Q45862137-51C00357-9708-4F40-AC35-037EE03DE3B2Q45863761-3D08AF15-59B8-4A38-86EB-AF95BF5468F5Q45865348-BC832521-551A-47A6-8667-51CF68C73E57Q45868914-139106A5-4173-4DF3-B29E-6438B154C6DAQ45875518-A9D0F48E-E5D3-4953-B15B-3B87D7CA4DC2Q45878125-FB76F8BF-05ED-48B9-ADEA-B1A9B32A1F37Q45883662-0C2B18CF-51A6-4B71-975A-28145BF504DEQ48462941-A0F65440-DDB1-4728-8FBE-A25D406B144E
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Antiangiogenic gene therapy.
@ast
Antiangiogenic gene therapy.
@en
type
label
Antiangiogenic gene therapy.
@ast
Antiangiogenic gene therapy.
@en
prefLabel
Antiangiogenic gene therapy.
@ast
Antiangiogenic gene therapy.
@en
P2860
P356
P1476
Antiangiogenic gene therapy.
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.16.9064
P407
P577
1998-08-01T00:00:00Z